Accessed 10 Oct 2022
Bcl-rambo, the mammalian homolog of ATG32, binds to LC3 through the WxxI motif, mediating mitophagy independently of ubiquitination [21]
This action reflects our responsibility to protect patients and preserve the integrity of the drug approval process while continuing to provide a transparent, science-based pathway for public input. The FDA carefully reviewed the nominations it received and did not identify sufficient evidence to include semaglutide, tirzepatide and liraglutide on the 503B bulks list
( 10.1530/EO-23-0015) [DOI] [PMC free article] [PubMed] [Google Scholar] 13.Ungvari Z, Bartha A, Ungvari A, et al
Some patients progress through dose increases every 4 weeks
Maternal obesity similarly disrupts autophagy/mitophagy pathways, contributing to metabolic disturbances that adversely impact fetal development and postnatal metabolic health